PerkinElmer Introduces a Pre-Clinical High-Throughput Bioluminescence Small Animal Imaging System

PerkinElmer Introduces a Pre-Clinical High-Throughput Bioluminescence Small Animal Imaging System

January 17, 2014 at 12:00 AM EST
SUMMARY: PerkinElmer introduces the IVIS® SpectrumBL, developed to enable the pharmaceutical and biotech industries to improve efficiencies in pre-clinical imaging studies by increasing in vivo throughput for drug efficacy, safety and toxicology.

The IVIS SpectrumBL high-throughput 2D and 3D optical imaging system is currently the only system that can simultaneously image up to 10 mice with full gas anesthesia incorporation along with ultra-high sensitivity to support bioluminescence, chemiluminescence and Cerenkov radioisotopic imaging. PerkinElmer's leading optical imaging technology facilitates non-invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals to enable customers to quantitatively evaluate drug efficacy. The IVIS SpectrumBL features a 5 and a 10 mouse anesthesia manifold for larger cohorts, offering robust in vivo data, as well as significantly increasing the potential number of compounds that can be screened in vivo in early stages of pre-clinical drug discovery.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $2.1 billion in 2012, has about 7,600 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Media Contact:

Anna Christensen
Director of Marketing- In Vivo Imaging, PerkinElmer
Email: anna.christensen@perkinelmer.com

Related Links

IR Contact

ir@perkinelmer.com
(781) 663 - 6900
940 Winter Street
Waltham, MA 02451
United States
www.perkinelmer.com

Transfer Agent

Mailing addresses
Correspondence should be mailed to:
Computershare
P.O. Box 505000
Louisville, KY 40233

Overnight correspondence should be sent to:
Computershare
462 South 4th Street, Suite 1600
Louisville, KY 40202

Shareholder website www.computershare.com/investor
Shareholder online inquiries
www-us.computershare.com/investor/Contact